some notes....IHL 42x- 50% reduction in AHI - absolutely massive...

some notes....

IHL 42x
- 50% reduction in AHI - absolutely massive results.
- About one month away from the FDA IND
- then PH 2/Ph3 blended study.

PSI - Gad
- PH2 results due at end of year.

IHL 675A
- Results PH 2 - back end of year or early 24.

Cannabanoid chewable products
- Opiod chewable gum.
- poised to disrupt the nicotine gum market - since this has nicotine + cannabinoid.
- pre IND meetings in Q3 this year
- Then scaling into PH 2 studies

Management own 25% of business = participated in every CR